| MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis A Terunuma, N Putluri, P Mishra, EA Mathé, TH Dorsey, M Yi, TA Wallace, ... The Journal of clinical investigation 124 (1), 398-412, 2014 | 414 | 2014 |
| CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ... Nature communications 7 (1), 12320, 2016 | 405 | 2016 |
| TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance Y Yang, ME Kohler, CD Chien, CT Sauter, E Jacoby, C Yan, Y Hu, ... Science translational medicine 9 (417), eaag1209, 2017 | 182 | 2017 |
| MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer RS Hudson, M Yi, D Esposito, SA Glynn, AM Starks, Y Yang, AJ Schetter, ... Oncogene 32 (35), 4139-4147, 2013 | 143 | 2013 |
| Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages DA Stewart, Y Yang, L Makowski, MA Troester Molecular Cancer Research 10 (6), 727-738, 2012 | 119 | 2012 |
| Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD E Jacoby, Y Yang, H Qin, CD Chien, JN Kochenderfer, TJ Fry Blood, The Journal of the American Society of Hematology 127 (10), 1361-1370, 2016 | 114 | 2016 |
| Challenges and opportunities of allogeneic donor-derived CAR T cells Y Yang, E Jacoby, TJ Fry Current opinion in hematology 22 (6), 509-515, 2015 | 114 | 2015 |
| Immunobiology of chimeric antigen receptor T cells and novel designs Z Walsh, Y Yang, ME Kohler Immunological Reviews 290 (1), 100-113, 2019 | 22 | 2019 |
| CD4 CAR T cells mediate CD8-like cytotoxic anti-leukemic effects resulting in leukemic clearance and are less susceptible to attenuation by endogenous TCR activation than CD8 … Y Yang, T Lin, E Jacoby, H Qin, EG Gardner, CD Chien, DW Lee III, TJ Fry Blood 126 (23), 100, 2015 | 16 | 2015 |
| Effect of chronic endogenous antigen stimulation on CAR T cell persistence and memory formation Y Yang, ME Kohler, TJ Fry Blood 130, 166, 2017 | 10 | 2017 |
| CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun 2016; 7: 12320 E Jacoby, SM Nguyen, TJ Fountaine, K Welp, B Gryder, H Qin, Y Yang, ... Curr Opin Hematol 26 (6), 427-433, 2019 | 7 | 2019 |
| Lineage switch as a relapse mechanism of pre-B acute lymphoblastic leukemia following CD19 CAR E Jacoby, SM Nguyen, KM Welp, H Qin, Y Yang, CD Chien, J Shern, ... Blood 126 (23), 2524, 2015 | 5 | 2015 |
| A direct comparison of the in vivo efficacy and in vitro signaling of chimeric antigen receptors and endogenous T cell receptors ME Kohler, Y Yang, G Sepulveda, TJ Fry Blood 130, 4451, 2017 | 4 | 2017 |
| Modeling retreatment of acute lymphoblastic leukemia with anti-CD19 chimeric antigen receptor T cell therapy Y Yang, ME Kohler, TJ Fry Blood 128 (22), 2806, 2016 | 2 | 2016 |
| Late ALL relapse following CD19 CAR immune-pressure demonstrates reversible pan-antigen loss E Jacoby, Y Yang, CD Chien, W Haso, H Qin, TJ Fry Cancer Research 75 (15_Supplement), 4705-4705, 2015 | 2 | 2015 |
| CD19 CAR T Cells Maintain Efficacy in the Allogeneic Environment but Mediate Acute Graft-Versus-Host-Disease Only in the Presence CD19+ Acute Lymphoblastic Leukemia E Jacoby, H Qin, Y Yang, CD Chien, TJ Fry Blood, The Journal of the American Society of Hematology 124 (21), 1115-1115, 2014 | 2 | 2014 |
| Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion E Jacoby, H Qin, J Kochenderfer, Y Yang, C Chien, T Fry Journal for ImmunoTherapy of Cancer 3, 1-1, 2015 | | 2015 |
| Presence of Endogenous TCR Antigen in Vivo Attenuates Efficacy of Anti-CD19 Targeted CAR T Cell Therapy Y Yang, CD Chien, E Jacoby, H Qin, W Haso, TJ Fry Blood 124 (21), 3721, 2014 | | 2014 |
